MD3215118T2 - Unitate de dispozitiv medical conţinând quinagolidă - Google Patents

Unitate de dispozitiv medical conţinând quinagolidă

Info

Publication number
MD3215118T2
MD3215118T2 MDE20170069T MDE20170069T MD3215118T2 MD 3215118 T2 MD3215118 T2 MD 3215118T2 MD E20170069 T MDE20170069 T MD E20170069T MD E20170069 T MDE20170069 T MD E20170069T MD 3215118 T2 MD3215118 T2 MD 3215118T2
Authority
MD
Moldova
Prior art keywords
drug
device unit
quinagolide
poly
unit containing
Prior art date
Application number
MDE20170069T
Other languages
English (en)
Inventor
Janet Halliday
Denis Carr
Alistair Ross
Claire Young
Paul Mcdonald
Mohammad Qadir
Robert Cochrane
Gouher Rabani
Saez Joan Carles Arce
Axel Niclas Petri
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51951583&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MD3215118(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MD3215118T2 publication Critical patent/MD3215118T2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/001—Combinations of extrusion moulding with other shaping operations
    • B29C48/0021—Combinations of extrusion moulding with other shaping operations combined with joining, lining or laminating
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2033/00—Use of polymers of unsaturated acids or derivatives thereof as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
    • B29K2105/0035—Medical or pharmaceutical agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor
    • B29L2031/754—Pessaries

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Prezenta invenţie se bazează pe identificarea unei cohorte de copolimeri bloc poliuretanici care sunt deosebit de adecvaţi pentru utilizare în unităţi de medicamente polimerice farmaceutice şi care oferă un control îmbunătăţit al eliberării medicamentului. În particular, este prevăzută o unitate polimerică de medicament-dispozitiv care cuprinde un copolimer bloc poliuretanic care poate fi obţinut prin reacţia împreună a unui poli (alchilen oxid); un compus difuncţional; un izocianat difuncţional; şi opţional un copolimer bloc care cuprinde blocuri poli (oxid de alchilen); şi chinagolida ca agent farmaceutic activ. Unităţile de medicamente pot găsi aplicaţii în tratamentul şi / sau prevenirea endometriozei.
MDE20170069T 2014-11-07 2015-11-05 Unitate de dispozitiv medical conţinând quinagolidă MD3215118T2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14192372.2A EP3017809A1 (en) 2014-11-07 2014-11-07 Drug-device unit containing quinagolide
PCT/EP2015/075849 WO2016071466A1 (en) 2014-11-07 2015-11-05 Drug-device unit containing quinagolide

Publications (1)

Publication Number Publication Date
MD3215118T2 true MD3215118T2 (ro) 2021-08-31

Family

ID=51951583

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20170069T MD3215118T2 (ro) 2014-11-07 2015-11-05 Unitate de dispozitiv medical conţinând quinagolidă

Country Status (33)

Country Link
US (2) US20180008535A1 (ro)
EP (3) EP3017809A1 (ro)
JP (2) JP6907120B2 (ro)
KR (1) KR102612852B1 (ro)
CN (2) CN116212032A (ro)
AR (1) AR102571A1 (ro)
AU (2) AU2015341734C1 (ro)
CA (1) CA2966473A1 (ro)
CL (1) CL2017001119A1 (ro)
CO (1) CO2017005578A2 (ro)
DK (1) DK3215118T3 (ro)
EA (2) EA033806B9 (ro)
ES (1) ES2877973T3 (ro)
HR (1) HRP20210961T1 (ro)
HU (1) HUE054951T2 (ro)
IL (1) IL252088B (ro)
JO (1) JO3561B1 (ro)
LT (1) LT3215118T (ro)
MA (2) MA40897B1 (ro)
MD (1) MD3215118T2 (ro)
MX (1) MX2017005828A (ro)
MY (1) MY193638A (ro)
PH (1) PH12017550005A1 (ro)
PL (1) PL3215118T3 (ro)
PT (1) PT3215118T (ro)
RS (1) RS62018B1 (ro)
SA (1) SA517381471B1 (ro)
SG (1) SG11201703596SA (ro)
SI (1) SI3215118T1 (ro)
TN (1) TN2017000175A1 (ro)
TW (1) TWI685339B (ro)
UA (1) UA122329C2 (ro)
WO (1) WO2016071466A1 (ro)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11896685B2 (en) 2018-10-31 2024-02-13 Amorepacific Corporation Core-shell network structure comprising biopolymer and composition comprising same
KR20210069344A (ko) 2019-12-03 2021-06-11 (주)아모레퍼시픽 바이오 폴리머를 포함하는 효능물질 전달체
WO2023031218A1 (en) 2021-08-31 2023-03-09 Ferring B.V. Diagnosis and treatment of ectopic endometriosis

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235988A (en) 1976-12-13 1980-11-25 Imperial Chemical Industries Limited Delivery means for biologically active agents
JP4898431B2 (ja) 2003-04-29 2012-03-14 ザ ジェネラル ホスピタル コーポレイション 複数薬物の持続放出のための方法およびデバイス
WO2005004837A1 (en) 2003-07-10 2005-01-20 Galen (Chemicals) Limited Intravaginal drug delivery devices
EP1682102A2 (en) * 2003-09-10 2006-07-26 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
CA2605972C (en) 2005-04-29 2011-08-02 Ferring International Center S.A. Treatment or prevention of ovarian hyperstimulation syndrome (ohss) using a dopamine agonist
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
SA08290041B1 (ar) 2007-02-01 2012-06-05 فيرينج انترناشونال سنتر اس آيه أدوية من أجل معالجة بطانة الرحم
EP2249811A1 (en) * 2008-01-25 2010-11-17 Grünenthal GmbH Pharmaceutical dosage form
WO2009094573A2 (en) 2008-01-25 2009-07-30 The University Of Utah Research Foundation Linear order release polymer
US20100040671A1 (en) 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
US20100210600A1 (en) * 2009-02-19 2010-08-19 Prelief Inc. Methods and Compositions for Treating Urogenital Disorders
TW201102066A (en) * 2009-06-26 2011-01-16 Ferring Int Ct Sa Treatment of endometriosis
CA2795289A1 (en) * 2010-04-08 2011-10-13 Sanford-Burnham Medical Research Institute Methods and compositions for enhanced delivery of compounds
US9393311B2 (en) 2010-11-15 2016-07-19 Dsm Ip Assets B.V. Intravaginal ring comprising polyurethane composition for drug delivery
EP2734262B1 (en) * 2011-07-20 2018-02-28 Patrick F. Kiser Intravaginal rings for drug delivery
US10137199B2 (en) * 2013-05-14 2018-11-27 Biotime, Inc. Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione
US10413504B2 (en) * 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system

Also Published As

Publication number Publication date
JO3561B1 (ar) 2020-07-05
PH12017550005A1 (en) 2017-10-18
MA40897A (fr) 2017-09-13
BR112017009476A2 (pt) 2018-01-02
AU2015341734B2 (en) 2020-08-20
TN2017000175A1 (en) 2018-10-19
RS62018B1 (sr) 2021-07-30
TW201625245A (zh) 2016-07-16
EA201991882A2 (ru) 2020-01-31
CN106999422A (zh) 2017-08-01
TWI685339B (zh) 2020-02-21
UA122329C2 (uk) 2020-10-26
EA033806B9 (ru) 2019-12-19
EP3017809A1 (en) 2016-05-11
US20220040094A1 (en) 2022-02-10
JP2021155444A (ja) 2021-10-07
CN116212032A (zh) 2023-06-06
LT3215118T (lt) 2021-06-10
EA201790898A1 (ru) 2017-11-30
WO2016071466A1 (en) 2016-05-12
AR102571A1 (es) 2017-03-08
PT3215118T (pt) 2021-05-31
DK3215118T3 (da) 2021-06-21
EP3215118A1 (en) 2017-09-13
CL2017001119A1 (es) 2018-01-05
JP2017533272A (ja) 2017-11-09
ES2877973T3 (es) 2021-11-17
KR102612852B1 (ko) 2023-12-11
SI3215118T1 (sl) 2021-08-31
KR20170080671A (ko) 2017-07-10
CO2017005578A2 (es) 2017-08-31
IL252088B (en) 2022-04-01
AU2020270480A1 (en) 2020-12-17
EA201790898A8 (ru) 2018-01-31
MY193638A (en) 2022-10-21
SG11201703596SA (en) 2017-06-29
EP3892261A1 (en) 2021-10-13
EP3215118B1 (en) 2021-03-17
PL3215118T3 (pl) 2021-07-26
EA033806B1 (ru) 2019-11-27
MX2017005828A (es) 2017-11-13
AU2015341734A1 (en) 2017-06-01
MA40897B1 (fr) 2021-04-30
HUE054951T2 (hu) 2021-10-28
IL252088A0 (en) 2017-07-31
US20180008535A1 (en) 2018-01-11
CA2966473A1 (en) 2016-05-12
HRP20210961T1 (hr) 2021-09-17
JP6907120B2 (ja) 2021-07-21
SA517381471B1 (ar) 2022-03-06
MA56414A (fr) 2022-05-04
AU2015341734C1 (en) 2020-12-17

Similar Documents

Publication Publication Date Title
MD3224256T2 (ro) Compuși N-((het)arilmetil)-heteroaril-carboxamidici în calitate de inhibitori ai kalikreinei plasmatice
MX2017015725A (es) Vectores virales adenoasociados para el tratamiento de mucopolisacaridosis.
MY187540A (en) Compounds active towards bromodomains
PH12016502248A1 (en) Adenoassociated virus vectors for the treatment of lysosomal storage disorders
MX363689B (es) Derivados de heterociclicos.
NZ733135A (en) Fused pyrimidine compounds for the treatment of hiv
NZ713946A (en) Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections
WO2015110969A3 (en) Nitrogen containing compounds and their use as antibacterial agents
MD3215118T2 (ro) Unitate de dispozitiv medical conţinând quinagolidă
NZ741318A (en) Compound for treating or preventing hyperuricemia or gout
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX364934B (es) Agente para prevenir y/o tratar dolor neuropático periférico causado por fármaco contra el cáncer.
ZA202006415B (en) Tetrabenazine transdermal delivery device
MX2018006194A (es) Peptidos con propiedades antiangiogenicas, antilinfangiogenicas y antiedemicas y formulaciones de nanoparticulas.
MX2016007626A (es) Peptido antimicrobiano y usos del mismo.
CY1119522T1 (el) (r)- πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη
MX2016009850A (es) Tratamientos novedosos.
MX2017000447A (es) Poliaminas de cadena principal.
PH12017501563A1 (en) Oligomeric/polymeric silicone fluids for use in transdermal drug delivery systems
TH1701002526A (th) หน่วยอุปกรณ์ส่งยาที่มีควินาโกไลด์
EA201791456A1 (ru) Пептиды-антагонисты cgrp
WO2016055111A8 (en) Amphiphilic copolymers their preparation and use for the delivery of drugs
IT201600069689U1 (it) Benda elastica, particolarmente per l’impiego nel trattamento del flebo-linfoedema.
UA101951U (uk) Фармацевтична композиція для лікування і профілактики застуди
GB201501717D0 (en) Galactose polymer gel dressing for wound healing and as a means of passive or active transdermal delivery of remedial agents